𝔖 Bobbio Scriptorium
✦   LIBER   ✦

RB1CC1 activates the promoter and expression of RB1 in human cancer

✍ Scribed by Kaichiro Ikebuchi; Tokuhiro Chano; Yasuko Ochi; Hitosuke Tameno; Taketoshi Shimada; Yasuo Hisa; Hidetoshi Okabe

Publisher
John Wiley and Sons
Year
2009
Tongue
French
Weight
416 KB
Volume
125
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

RB1‐inducible coiled‐coil 1 (RB1CC1, also known as FIP200) is a tumor suppressor implicated in the regulation of RB1 (retinoblastoma 1) expression. However, the molecular mechanism of RB1 regulation by RB1CC1 has not been elucidated. Here, we demonstrate that nuclear RB1CC1 binds to the RB1 promoter using chromatin immunoprecipitation assays with anti‐RB1CC1 antibody. Luciferase assays with RB1 promoter reporter plasmids revealed that RB1CC1 activated the RB1 promoter through the 201 bp upstream GC‐rich region (from the initiation ATG). Electrophoretic mobility shift assay and Western blot analysis supported RB1CC1 binding to the GC‐rich region of the RB1 promoter. In addition, the C‐terminus of RB1CC1 was required for nuclear localization and subsequent RB1 promoter activation. Furthermore, the expression levels of RB1CC1 and RB1 significantly correlated with in vivo breast cancer tissues as determined by immunohistochemical analysis. These data indicate that nuclear RB1CC1 directly activates the RB1 promoter to enhance RB1 expression in cancer cells. Evaluation of RB1CC1 in various types of human cancer tissues is expected to provide useful information for clinical practice and future therapeutic strategies. © 2009 UICC

📜 SIMILAR VOLUMES

Conservation of the RB1 gene in human an
Conservation of the RB1 gene in human and primates
✍ Theru A. Sivakumaran; Peidong Shen; Dennis P. Wall; Bao H. Do; Kiran Kucheria; P 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB

## Communicated by Georgia Chenevix-Trench Mutations in the RB1 gene are associated with retinoblastoma, which has served as an important model for understanding hereditary predisposition to cancer. Despite the great scrutiny that RB1 has enjoyed as the prototypical tumor suppressor gene, it has ne

p53, Rb, and cyclin D1 expression in hum
p53, Rb, and cyclin D1 expression in human oral verrucous carcinomas
✍ Irma B. Gimenez-Conti; Ana M. Collet; Hector Lanfranchi; Maria E. Itoiz; Mario L 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 835 KB

## Background: The verrucous carcinoma (vc), a tumor with low grade malignancy, appears to be associated with tobacco and human papillomavirus. the pathobiology of these tumors has not been extensively studied, and molecular genetic alterations have not been reported. in this study we investigated

Low frequency of oncogenic mutations in
Low frequency of oncogenic mutations in the core promoter region of the RB1 gene
✍ Tsuyoshi Fujita; Naoko Ohtani-Fujita; Toshiyuki Sakai; Joyce M. Rapaport; Thadde 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 2 views

Inactivation of the human retinoblastoma tumor-suppressor gene (RB1; MIM # 180200) is usually caused by mutations in the coding region, but mutations in the promoter region can also affect RB1 gene expression. A 103-bp deletion in the promoter region in a prostate cancer was reported to abrogate RB1

Expression and enzyme activity of α(1,6)
Expression and enzyme activity of α(1,6)fucosyltransferase in human colorectal cancer
✍ Laura Muinelo-Romay; Cristina Vázquez-Martín; Susana Villar-Portela; Elisa Cueva 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 210 KB

## Abstract Changes in enzyme activity and the expression levels of α(1,6)fucosyltransferase [α(1,6)FT] have been reported in certain types of malignant transformations. To develop a better understanding of the role of α(1,6)FT in human colorectal carcinoma (CRC), we analysed the enzyme activity in